Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex-Reference-Cited by-同舟云学术

Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex

Published:2014-09-17 Issue:6 Volume:220 Page:3701-3720
ISSN:1863-2653
Container-title:Brain Structure and Function
language:en
Short-container-title:Brain Struct Funct

Author:

García-Díaz Beatriz,Riquelme Raquel,Varela-Nieto Isabel,Jiménez Antonio Jesús,de Diego Isabel,Gómez-Conde Ana lsabel,Matas-Rico Elisa,Aguirre José Ángel,Chun Jerold,Pedraza Carmen,Santín Luis Javier,Fernández Oscar,Rodríguez de Fonseca Fernando,Estivill-Torrús Guillermo

Publisher

Springer Science and Business Media LLC

Subject

Histology,General Neuroscience,Anatomy

Link

http://link.springer.com/content/pdf/10.1007/s00429-014-0885-7.pdf

Reference102 articles.

1. Allard J, Barron S, Diaz J, Lubetzki C, Zalc B, Schwartz JC, Sokoloff P (1998) A rat G protein-coupled receptor selectively expressed in myelin-forming cells. Eur J Neurosci 10:1045–1053

2. Anliker B, Chun J (2004) Lysophospholipid G protein-coupled receptors. J Biol Chem 279:20555–20558

3. Anliker B, Choi JW, Lin ME, Gardell SE, Rivera RR, Kennedy G, Chun J (2013) Lysophosphatidic acid (LPA) and its receptor, LPA1, influence embryonic schwann cell migration, myelination, and cell-to-axon segregation. Glia 61:2009–2022

4. Baslow MH (2003) N-Acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28:941–953

5. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871–927

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysophosphatidic Acid Receptors LPAR5 and LPAR2 Inversely Control Hydroxychloroquine-Evoked Itch and Scratching in Mice;International Journal of Molecular Sciences;2024-07-26

2. Lysophosphatidic acid receptor 1 influences disease severity in a mouse model of multiple sclerosis;2024-06-02

3. Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes;Scientific Reports;2024-02-21

4. It takes two to remyelinate: A bioengineered platform to study astrocyte-oligodendrocyte crosstalk and potential therapeutic targets in remyelination;Biomaterials Advances;2023-08

5. From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions;Acta Neuropathologica;2023-06-07